Galafold 123 MG
Ended Awarded
- Contract number
- 36C24526N0125
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,891
Award facts
- Contract value 100% obligated
- $21,891.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to Amicus Therapeutics US, LLC on October 29, 2025, for the supply of Galafold 123 mg, a specialized pharmaceutical product used to treat Fabry disease. This firm fixed-price delivery order, valued at $21,891.21 with completion scheduled for October 31, 2025, will be delivered to a VA facility in Philadelphia, Pennsylvania. The award was made under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract (36F79724D0185), a multiple-award vehicle valued at $13.0 million and valid through August 31, 2029. No set-aside designation was utilized for this procurement.
Amicus Therapeutics US, LLC, a biopharmaceutical company specializing in treatments for rare genetic diseases, serves as the prime contractor with no identified subcontractors. The company has established itself as a key supplier of Galafold to the VA across multiple VISN regions nationwide. This delivery order supports the VA's mission to provide specialized healthcare services and medications to veterans, enabling VA healthcare facilities to efficiently obtain this enzyme replacement therapy for eligible patients requiring treatment for Fabry disease.
Quick answers
Who was awarded contract 36C24526N0125?
36C24526N0125 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 29, 2025.
How much is contract 36C24526N0125 worth?
The government has obligated $21,891 on 36C24526N0125.
Is contract 36C24526N0125 an order under another contract?
Yes. 36C24526N0125 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0125 competed?
The extent of competition for 36C24526N0125 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award